Advertisement

Topics

Latest "Chiral Technologies" News Stories

00:53 EDT 18th July 2018 | BioPortfolio

Here are the most relevant search results for "Chiral Technologies" found in our extensive news archives from over 250 global news sources.

More Information about Chiral Technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Chiral Technologies for you to read. Along with our medical data and news we also list Chiral Technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Chiral Technologies Companies for you to search.

Showing "Chiral Technologies" News Articles 1–25 of 5,600+

Relevant

Scientists Discover 'Chiral Phonons'--Atomic Rotations in a 2-D Semiconductor Crystal

Experiments confirm the first chiral phonon that could enable exotic forms of electronics


Machine Learning Offers New Way of Designing Chiral Crystals

NewsLogistic regression analysis model predicts ideal chiral crystal.Contributed Author: 

Scientists Discover 'Chiral Phonons'— Atomic Rotations in a 2D Semiconductor Crystal

NewsExperiments confirm the first chiral phonon that could enable exotic forms of electronics.Contributed Author: 


Chiral Separations With Magnets. No, For Real.

Now here is something I didn’t expect: what may well be a completely new way to separate enantiomers, not based in any way on shape recognition versus another chiral substance. [Quick background for those not in the field: a great many three-dimensional molecules can exist in right-handed and left-handed mirror-image forms (enantiomers), exactly like pairs

Chemists invent new method for remote chiral induction

Chemists at Scripps Research have addressed one of the most formidable challenges in synthetic chemistry by inventing a method for "enantioselective remote meta-CH activation," which enables the making of chiral molecules that were previously difficult or impossible to synthesize.

Chiral heterocycles

Enantioselective remote meta-C–H arylation and alkylation via a chiral transient mediator

Chemists achieve major milestone of synthesis: Remote chiral induction

(Scripps Research Institute) 'This new method should allow us to explore a large 'chemical space' that had been essentially off-limits.'

A Simple Route to Highly Chiral Materials

NewsChirality is at the heart of chemical research and much technology.

Prominent biotech and healthcare entrepreneur Dr Stephen Parker joins Liverpool ChiroChem as Chairman

Liverpool ChiroChem (LCC), the specialist supplier of chiral small molecules that are used as building blocks, fragments, active pharmaceutical ingredients (API) and intermediates in small molecule drug discovery, is pleased to announce the appointment of Dr Stephen Parker as Non-executive Chairman of the company.The appointment of Dr Parker marks a new growth phase for the Liverpool University sp...

Park Place Technologies Acquires Axentel Technologies

The Axentel Technologies acquisition allows Park Place Technologies to significantly enhance its ability to service customers in Singapore, Malaysia, Hong Kong, Thailand Read more...

Park Place Technologies adquiere Axentel Technologies

La adquisición de Axentel Technologies permite a Park Place Technologies mejorar considerablemente su capacidad de prestar servicios a clientes en Singapur, Malasia, Hong Kong, Read more...

Agilent Technologies agrees to acquire Advanced Analytical Technologies

Agilent Technologies Inc. agreed to acquire privately held Advanced Analytical Technologies Inc. (AAT; develops and sells hig...

Probably Relevant

Syncom BV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14032018] Prices from USD $250

SummarySyncom BV Syncom is a provider of custom synthesis solutions. The company's activities include synthesis of key building blocks, route scouting services, process research activities and medicinal chemistry services. Its service portfolio includes contract research services, chiral technology services, medicinal chemistry services and analytical services. The company also offers customized s...

InterGlobe Technologies fonde son premier centre mondial de prestation de services à Bogota, ...

InterGlobe Technologies (IGT), l'un des principaux fournisseurs de services et solutions IT-BPM (technologies de l'information - gestion des processus d'affaires) et numériques intégrés, a annoncé Read more...

Peptide induces chirality evolution in a single gold nanoparticle

(Seoul National University) Seoul National University has created a synthesis method to make optically active and chiral gold nanoparticles using amino acids and peptides for the first time. Many chemicals significant to life have mirror-imaged twins and such characteristics are conventionally called as chirality. This study describes how the chirality, typically observed in organic molecules, can...

This Morning's Technical Outlook on Medical Research Stocks -- Agilent Technologies, ...

www.wallstequities.com/registration Agilent Technologies Santa Clara, Californiaheadquartered Agilent Technologies Inc.'s shares gained slightly by 0.37%, closing Thursday's trading session at $70.18. The stock recorded Read more...

Free Research Reports on These Medical Supplies Stocks -- OraSure Technologies, Precision ...

www.wallstequities.com/registration OraSure Technologies Bethlehem, Pennsylvania-based OraSure Technologies Inc.'s stock finished Thursday's session 0.98% lower at $18.28with a total trading volume of 525,739 shares. Read more...

Living Cell Technologies: New Technologies and Clinical Trials

In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Paul Tan, CEO of Living Cell Technologies. Filmed at AusBiotech 2009, they discuss: • The company’s origins and aims • Pig islet transplantation to combat diabetes • Results of Russian and New Zealand clinical trials • Living Cell Technologies’ issues with clinical trials in Australia • The company’s searc...

StemCell Technologies licenses otolaryngology IP from Indiana U.

Life sciences research company StemCell Technologies Inc. exclusively licensed intellectual property related to inner ear org...

Double Helix Technologies teams-up with Agilent Technologies to offer the SureVector Cloning System

Venice, Italy, 10th October 2017 / Sciad Newswire / Double Helix Technologies (Doulix) announced today a collaboration with Agilent Technologies Inc. (NYSE: A) to promote Agilent's SureVector next-generation cloning kits through Doulix’s web platform. Through this partnership, synthetic biologists will be able to choose among SureVector’s standard DNA parts to design custom plasmids using ...

Bio-Techne to acquire Quad Technologies

Bio-Techne Corporation announced it has reached agreement to acquire all of the stock of QT Holdings Corporation d/b/a Quad Technologies. The transaction is expected to close in early July and to be financed through available cash on hand. "We are extremely excited to welcome Quad Technologies and i...

Two Technologies Introduce New Product

HORSHAM, Pa., Feb. 12, 2018/PRNewswire/ -- Two Technologies, the leading manufacturer of ultra-rugged all-in-one hand-held devices in North America, which prides itself on Read more...

Microgrids: Technologies and Global Markets

NEW YORK, April 3, 2018/PRNewswire/ -- Report Scope: This market study assesses the leading microgrid technologies that are currently in use globally for Read more...

American Gene Technologies: the first bio-safe gene delivery vector for human clinical therapeutic use

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with Jeff Galvin, Chief Executive Officer at American Gene Technologies, a genetic research firm focusing on gene therapies for cancer They discuss: • the origins of American Gene Technologies • targeting cancers with gene therapy as a priority • types of viral vectors and their immune responses • acquiring fun...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks